{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:31:55Z","timestamp":1773678715758,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajem.2026.02.011","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:16:57Z","timestamp":1770657417000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between tailored prescriber training and buprenorphine treatment for opioid use disorder among emergency medicine clinicians"],"prefix":"10.1016","volume":"103","author":[{"given":"Mark C.","family":"Bicket","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Dahlem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Dora-Laskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad M.","family":"Brummett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidhya","family":"Gunaseelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith E.","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2026.02.011_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.2024.11977","article-title":"Major gaps in the cascade of care for opioid use disorder: implications for clinical practice","volume":"332","author":"Arwady","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2026.02.011_bb0010","series-title":"Provisional drug overdose death counts","author":"Centers for Disease Control and Prevention (U.S.)","year":"2025"},{"key":"10.1016\/j.ajem.2026.02.011_bb0015","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on health sciences policy, committee on medication-assisted treatment for opioid use disorder","year":"2019"},{"key":"10.1016\/j.ajem.2026.02.011_bb0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates - United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajem.2026.02.011_bb0025","author":"CDC Web-based Injury Statistics Query and Reporting System"},{"key":"10.1016\/j.ajem.2026.02.011_bb0030","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2026.02.011_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/acem.14369","article-title":"\u201cThis is part of emergency medicine now\u201d: a qualitative assessment of emergency clinicians\u2019 facilitators of and barriers to initiating buprenorphine","volume":"29","author":"Schoenfeld","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.annemergmed.2020.02.020","article-title":"Providing incentive for emergency physician X-waiver training: an evaluation of program success and postintervention buprenorphine prescribing","volume":"76","author":"Foster","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMc1905045","article-title":"Statewide implementation of postoperative opioid prescribing guidelines","volume":"381","author":"Vu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.annemergmed.2019.04.033","article-title":"Baseline performance of real-world clinical practice within a statewide emergency medicine quality network: the Michigan emergency department improvement collaborative (MEDIC)","volume":"75","author":"Kocher","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.42786","article-title":"Adoption of emergency department-initiated buprenorphine for patients with opioid use disorder: secondary analysis of a cluster randomized trial","volume":"6","author":"Gao","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0080","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc2312906","article-title":"Buprenorphine dispensing after elimination of the waiver requirement","volume":"390","author":"Chua","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2026.02.011_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.25999","article-title":"Buprenorphine prescribing characteristics following relaxation of X-waiver training requirements","volume":"7","author":"Christine","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108568","article-title":"Prevalence and charges of opioid-related visits to U.S. emergency departments","volume":"221","author":"Langabeer","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajem.2026.02.011_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15287","article-title":"Trends and disparities in access to buprenorphine treatment following an opioid-related emergency department visit among an insured cohort, 2014-2020","volume":"5","author":"Stevens","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2021.7374","article-title":"Use of medications for treatment of opioid use disorder among US Medicaid enrollees in 11 states, 2014-2018","volume":"326","author":"Medicaid Outcomes Distributed Research Network (MODRN)","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2026.02.011_bb0105","article-title":"Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system","volume":"2020","author":"Madras","year":"2020","journal-title":"NAM Perspect"},{"key":"10.1016\/j.ajem.2026.02.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7028","article-title":"Assessment of community-level vulnerability and access to medications for opioid use disorder","volume":"5","author":"Joudrey","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/emp2.13265","article-title":"Emergency department management of opioid use disorder in pediatric patients","volume":"5","author":"Schwarz","year":"2024","journal-title":"JACEP Open"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:22:34Z","timestamp":1773674554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675726000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":22,"alternative-id":["S0735675726000835"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2026.02.011","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between tailored prescriber training and buprenorphine treatment for opioid use disorder among emergency medicine clinicians","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2026.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}